http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
임주혁,소형진,허홍,민경륜,이혜영,최순영,류재환,조인영,Im, Ju-Hyuk,So, Hyung-Jin,Heo, Hong,Min, Kyoung-Yoon,Lee, Hae-Yong,Choi, Soon-Young,Ryu, Jae-Hwan,Cho, In-Young 대한한방내과학회 2007 大韓韓方內科學會誌 Vol.28 No.3
We made a comparative study, A patient who had suffered dizziness and ataxia took Hyungbangsabaek-san(荊防瀉白散) at first and next took Hyungbangdojeock-san(荊防導赤散). He was diagnosed as a Soyangin suffering chest knotting syndrome(結胸證) by Sasang constitutional medicine(四象醫學) and took two kinds of herbs in a row. We observed his phase of dizziness and ataxia with the conditions of stool and urine excavation, pink eye, sweating, and tongue color and tongue coating. When he took Hyungbangdojeock-san these conditions improved more than when he took the other one and his dizziness and ataxia also improved. Hyungbangdojeock-san was more useful when the severity of the disease was shallower and he had more exterior syndromes than Hyungbangsabaek-san.
프리스트레스트 중공 슬래브와 현장타설된 토핑콘크리트의 수평전단성능 평가
임주혁,박민국,이득행,서수연,김강수 한국콘크리트학회 2014 콘크리트학회논문집 Vol.26 No.6
프리스트레스트 중공(PHC) 슬래브는 장경간에 적합하도록 경량화된 효율적인 프리캐스트 부재이며, 국내·외에서 많이사용되고 있다. 특히, 국내에서는 현장타설콘크리트와 같이 사용되는 합성슬래브 형태로 주로 적용되고 있다. 그러나, 압출성형방식으로 제작되는 PHC 슬래브 부재는 매우 낮은 슬럼프의 콘크리트로 제작되어 타설 직후에도 표면경도가 높기 때문에 계면의거친면 처리 및 전단연결재 배치가 어려운 단점이 있다. 이 연구에서는 PHC slab 부재와 토핑콘크리트 사이의 합성성능을 고찰하기 위하여 다양한 계면상태를 변수로 직접전단실험을 수행하였으며, 기존 실험결과를 수집하여 국내·외 수평전단강도 설계기준을 평가하였다.
Wearing-off 현상을 경험하는 파킨슨병 환자에서 엔타카폰의 효과 및 안정성: 다기관 무작위 위약비교 이중맹검 연구
임주혁,이종균,정선주,전범석,조진환,이명식,조은경,이원용,이은아,김재우,이명종 대한신경과학회 2005 대한신경과학회지 Vol.23 No.2
Background: The purpose of this study was to assess the efficacy and safety of entacapone, a catechol-O- methyltransferase (COMT) inhibitor in Parkinson's disease (PD) patients with wearing-off phenomenon. Methods: A total of 197 PD patients were included in this 2-month multi-center, randomized, placebo-controlled, double blind, parallel-group study. After a 2-week screening period, each patient was randomly allocated to receive either entacapone (n=98) or placebo (n=99) as an adjunct to levodopa. The efficacy was evaluated with the changes of “on” and “off” time percentage while awake, the reduction of the levodopa dose, Unified Parkinson's Disease Rating Scale (UPDRS), and the clinical global impression (CGI) by the examiner. Results: The percentage of “on” time increased by 9.4±18.0% in the entacapone group, 7.4±15.6% in the placebo group. The percentage of “off” time was reduced by 8.6±16.9% in the entacapone group, 6.6±18.2% in the placebo group. These parameters did not show a statistical significance between the two groups. However, the levodopa dose was significantly reduced in the entacapone group (51.6±154.5 mg/day) compared with the placebo group (0.7±130.0 mg/day) (p=0.009). The total and motor scores of the UPDRS were significantly decreased in the entacapone group (p=0.039, p=0.017, respectively). The most common adverse drug reactions in the entacapone group were urine discoloration (22%), dyskinesia (13%), dizziness (7%). Conclusions: Entacapone was a safe and well-tolerated drug. Although the changes of “on” and “off” time were not significant, entacapone showed an overall significant beneficial effect in the PD patients with wearing-off phenomenon. Background: The purpose of this study was to assess the efficacy and safety of entacapone, a catechol-O- methyltransferase (COMT) inhibitor in Parkinson's disease (PD) patients with wearing-off phenomenon. Methods: A total of 197 PD patients were included in this 2-month multi-center, randomized, placebo-controlled, double blind, parallel-group study. After a 2-week screening period, each patient was randomly allocated to receive either entacapone (n=98) or placebo (n=99) as an adjunct to levodopa. The efficacy was evaluated with the changes of “on” and “off” time percentage while awake, the reduction of the levodopa dose, Unified Parkinson's Disease Rating Scale (UPDRS), and the clinical global impression (CGI) by the examiner. Results: The percentage of “on” time increased by 9.4±18.0% in the entacapone group, 7.4±15.6% in the placebo group. The percentage of “off” time was reduced by 8.6±16.9% in the entacapone group, 6.6±18.2% in the placebo group. These parameters did not show a statistical significance between the two groups. However, the levodopa dose was significantly reduced in the entacapone group (51.6±154.5 mg/day) compared with the placebo group (0.7±130.0 mg/day) (p=0.009). The total and motor scores of the UPDRS were significantly decreased in the entacapone group (p=0.039, p=0.017, respectively). The most common adverse drug reactions in the entacapone group were urine discoloration (22%), dyskinesia (13%), dizziness (7%). Conclusions: Entacapone was a safe and well-tolerated drug. Although the changes of “on” and “off” time were not significant, entacapone showed an overall significant beneficial effect in the PD patients with wearing-off phenomenon.
원산지별 홍삼투여에 따른 백서의 자연살해세포 활성도 변화에 대한 연구
임주혁,조인영,민경윤,이혜영,김슬지,박영주,류재환,이범준,김성욱,주일우,Im, Ju-Hyuk,Cho, In-Young,Min, Kyoung-Yoon,Lee, Hae-Yong,Kim, Seul-Ji,Park, Young-Ju,Lew, Jae-Hwan,Lee, Beom-Joon,Kim, Sung-Wook,Joo, Il-Woo 대한한방내과학회 2008 大韓韓方內科學會誌 Vol.29 No.4
Objectives : The purpose of this experiment is comparing the difference on natural killer cell activity through Korean red ginseng and Chinese red ginseng by $^{51}Cr$ release assay. Methods : Thirty rats were equally divided into a Korean red ginseng group, a Chinese red ginseng group and a control group. Korean and Chinese red ginseng were administrated to the rats at 200mg daily for a weak, while 0.9% normal saline was given to the control. Percent specific lysis (PSL) and lytic units (LU) were calculated from spleen cells by $^{51}Cr$ release assay. Results : Percent specific lysis of the Korean red ginseng group was significantly higher than that of the control in the ratio of 100:1, effector cell:target cell (p<0.05). Percent specific lysis of Korean red ginseng group was also significantly higher than that of the Chinese red ginseng group in the ratio of 25:1, effector cell:target cell (p<0.05). Chinese red ginseng showed no effect on NK cell activity. Conclusions : These findings suggest that Korean red ginseng improves immunologic function and shows superior effects than Chinese red ginseng.